E-ISSN 0976-2779 | ISSN 0975-8453
 

Review Article 


Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia

Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani.

Abstract
This study aims to evaluate the financial performance of a pharmaceutical company that has been listed on the Indonesia Stock Exchange (IDX). The sample objects that the authors use in this study are nine pharmaceutical companies listed on the Indonesia Stock Exchange during the 2014-2018 period. The method of evaluating financial performance that I use is to use financial ratio analysis consisting of; liquidity ratios, activity ratios, solvency ratios, and profitability ratios and have been supplemented by DuPont analysis. The results that the authors get in this study prove that all financial ratios during the observation period experienced quite fluctuating changes. The liquidity ratio shows a high enough number which means that under the company's ability to pay off short-term liabilities, it is quite strong. The results of the calculation of the activity ratio obtained by the author also gives results that show that some pharmaceutical companies are quite efficient in the use of their assets in a company. The solvency ratio obtained by the authors from observations in the study period shows that pharmaceutical companies also have a debt large enough to be risky because of high interest and principal costs in payments. Earnings obtained by shareholders are quite large as indicated by profitability ratios through the analysis of three analyzes namely the analysis of ROI, ROE and DuPont which have positive values.

Key words: Financial performance, liquidity, activity, solvency, profitability DuPont


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Endri Endri
Articles by Desi Susanti
Articles by Lamminar Hutabarat
Articles by Torang P. Simanjuntak
Articles by Susi Handayani
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani. Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia. SRP. 2020; 11(6): 803-816. doi:10.31838/srp.2020.6.117


Web Style

Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani. Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia. http://www.sysrevpharm.org//?mno=119068 [Access: June 26, 2020]. doi:10.31838/srp.2020.6.117


AMA (American Medical Association) Style

Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani. Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia. SRP. 2020; 11(6): 803-816. doi:10.31838/srp.2020.6.117



Vancouver/ICMJE Style

Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani. Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia. SRP. (2020), [cited June 26, 2020]; 11(6): 803-816. doi:10.31838/srp.2020.6.117



Harvard Style

Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani (2020) Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia. SRP, 11 (6), 803-816. doi:10.31838/srp.2020.6.117



Turabian Style

Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani. 2020. Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia. Systematic Reviews in Pharmacy, 11 (6), 803-816. doi:10.31838/srp.2020.6.117



Chicago Style

Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani. "Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia." Systematic Reviews in Pharmacy 11 (2020), 803-816. doi:10.31838/srp.2020.6.117



MLA (The Modern Language Association) Style

Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani. "Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia." Systematic Reviews in Pharmacy 11.6 (2020), 803-816. Print. doi:10.31838/srp.2020.6.117



APA (American Psychological Association) Style

Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani (2020) Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia. Systematic Reviews in Pharmacy, 11 (6), 803-816. doi:10.31838/srp.2020.6.117





Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study
    Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli
    SRP. 2020; 11(1): 01-06
    » Abstract » doi: 10.5530/srp.2020.1.01

  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context
    Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran
    SRP. 2020; 11(1): 14-22
    » Abstract » doi: 10.5530/srp.2020.1.03

  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata
    Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi
    SRP. 2019; 10(1): 15-19
    » Abstract » doi: 10.5530/srp.2019.1.3

  • A Review of Pharmacoeconomics: the key to “Healthcare for All”
    Hasamnis AA, Patil SS, Shaik Imam, Narendiran K
    SRP. 2019; 10(1): s40-s42
    » Abstract » doi: 10.5530/srp.2019.1s.21

  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer
    Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova
    SRP. 2019; 10(1): 112-117
    » Abstract » doi: 10.5530/srp.2019.1.19

  • Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study
    Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli
    SRP. 2020; 11(1): 01-06
    » Abstract » doi: 10.5530/srp.2020.1.01

  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review
    Karle Pravin P, Dhawale Shashikant C
    SRP. 2019; 10(1): 11-14
    » Abstract » doi: 0.5530/srp.2019.1.2

  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba
    Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar
    SRP. 2019; 10(1): 20-25
    » Abstract » doi: 10.5530/srp.2019.1.4

  • A Review of Pharmacoeconomics: the key to “Healthcare for All”
    Hasamnis AA, Patil SS, Shaik Imam, Narendiran K
    SRP. 2019; 10(1): s40-s42
    » Abstract » doi: 10.5530/srp.2019.1s.21

  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata
    Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi
    SRP. 2019; 10(1): 15-19
    » Abstract » doi: 10.5530/srp.2019.1.3

  • Most Cited Articles